Joint Report of the Fifth International Workshop on Lymphocyte Alloantigens of the Horse, Baton Rouge, Louisiana, 31 October-1 November 1987.
Six laboratories participated in the Fifth International Workshop on Lymphocyte Alloantigens of the Horse, testing 132 alloantisera against lymphocytes of 880 horses chosen to represent different families and breeds. Most of the alloantisera were produced by lymphocyte immunization between horses matched at the ELA-A locus. All horses were also tested with antisera contributed to the workshop by participating laboratories which identified ELA specificities A1-A10 and W12-W21. Previously identified workshop specificities ELA-W14, W15 and W19 were accepted as products of the ELA-A locus based on family and population studies by the workshop. Their designations were changed to ELA-A14, ELA-A15 and ELA-A19, respectively. Two new specificities were identified, namely ELA-W22 (W22) and ELA-W23 (W23). Population and family studies indicated that W22 and W23 as well as W13 are products of an ELA locus other than ELA-A. The presence of these specificities was correlated with the presence of certain ELA-A locus specificities, e.g. W13 with A3, W22 with A2 and W23 with A5. However, the association was not complete and W13, W22 and W23 also segregated with other ELA-A specificities in some families. Evidence for recombination was found between the ELA-A locus and the locus or loci encoding these specificities resulting in seven recombinant haplotypes found among the data presented in this workshop. Further studies are required for definitive assignment of the specificities to a class I or class II locus.
Lazary
S
S
Division of Immunogenetics, School of Veterinary Medicine, University of Berne, Switzerland.
Antczak
D F
DF
Bailey
E
E
Bell
T K
TK
Bernoco
D
D
Byrns
G
G
McClure
J J
JJ
D000818:Animals; D001788:Blood Grouping and Crossmatching / Q000662:veterinary; D000939:Epitopes / Q000235:genetics / Q000276:immunology; D005787:Gene Frequency; D006649:Histocompatibility Antigens / Q000032:analysis / Q000235:genetics / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000032:analysis / Q000235:genetics / Q000276:immunology; D006736:Horses / Q000235:genetics / Q000276:immunology*; D007519:Isoantigens / Q000032:analysis* / Q000235:genetics / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D008285:Major Histocompatibility Complex
D000939:Epitopes; D006649:Histocompatibility Antigens; D000949:Histocompatibility Antigens Class II; D007519:Isoantigens